IL49080A - 4-hydroxy-4-(substituted)phenyl-piperidinomethyl-2-tetralone(or indanone)derivatives, their preparation and pharmaceutical compositions comprising them - Google Patents

4-hydroxy-4-(substituted)phenyl-piperidinomethyl-2-tetralone(or indanone)derivatives, their preparation and pharmaceutical compositions comprising them

Info

Publication number
IL49080A
IL49080A IL49080A IL4908076A IL49080A IL 49080 A IL49080 A IL 49080A IL 49080 A IL49080 A IL 49080A IL 4908076 A IL4908076 A IL 4908076A IL 49080 A IL49080 A IL 49080A
Authority
IL
Israel
Prior art keywords
piperidinomethyl
tetralone
indanone
hydroxy
phenyl
Prior art date
Application number
IL49080A
Other languages
English (en)
Other versions
IL49080A0 (en
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19752507782 external-priority patent/DE2507782A1/de
Priority claimed from DE19752556196 external-priority patent/DE2556196A1/de
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of IL49080A0 publication Critical patent/IL49080A0/xx
Publication of IL49080A publication Critical patent/IL49080A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/52Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL49080A 1975-02-22 1976-02-22 4-hydroxy-4-(substituted)phenyl-piperidinomethyl-2-tetralone(or indanone)derivatives, their preparation and pharmaceutical compositions comprising them IL49080A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19752507782 DE2507782A1 (de) 1975-02-22 1975-02-22 Tetralon- und indanon-derivate sowie verfahren zu ihrer herstellung
DE19752556196 DE2556196A1 (de) 1975-12-13 1975-12-13 Tetralon- und indanon-derivate sowie verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
IL49080A0 IL49080A0 (en) 1976-04-30
IL49080A true IL49080A (en) 1979-09-30

Family

ID=25768542

Family Applications (1)

Application Number Title Priority Date Filing Date
IL49080A IL49080A (en) 1975-02-22 1976-02-22 4-hydroxy-4-(substituted)phenyl-piperidinomethyl-2-tetralone(or indanone)derivatives, their preparation and pharmaceutical compositions comprising them

Country Status (16)

Country Link
US (1) US4016281A (hu)
JP (1) JPS51110573A (hu)
AT (1) AT353270B (hu)
CA (1) CA1081233A (hu)
CS (2) CS190525B2 (hu)
DD (1) DD124977A5 (hu)
DK (1) DK72476A (hu)
ES (1) ES445367A1 (hu)
FR (1) FR2301253A1 (hu)
GB (1) GB1477293A (hu)
HU (1) HU173756B (hu)
IE (1) IE42486B1 (hu)
IL (1) IL49080A (hu)
LU (1) LU74390A1 (hu)
NL (1) NL7601762A (hu)
SE (1) SE7601962L (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2177085A (en) * 1985-06-18 1987-01-14 Ici Plc Fungicidal compounds and compositions
HU222726B1 (hu) * 1990-02-06 2003-09-29 Pfizer, Inc., Piperidinszármazékok, eljárás elżállításukra és az ezeket tartalmazó gyógyszerkészítmények
EP0535496A1 (en) * 1991-09-25 1993-04-07 Hoechst-Roussel Pharmaceuticals Incorporated (1-Indanon-2yl)methylpiperidines, intermediates and a process for their preparation and their use as medicaments
DE4140542A1 (de) * 1991-12-09 1993-06-17 Bayer Ag Piperdylmethyl substituierte chormanderivate
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
BR9408506A (pt) * 1994-01-31 1997-08-05 Pfizer Compostos neuroprotetores
CA2220649C (en) * 1996-12-03 2007-02-13 F. Hoffmann-La Roche Ag 4-hydroxy-piperidine derivatives
CA2556914A1 (en) 2004-02-25 2005-09-09 La Jolla Pharmaceutical Company Amines and amides for the treatment of diseases
JPWO2005085228A1 (ja) * 2004-03-05 2008-01-17 萬有製薬株式会社 シクロアルカノピリジン誘導体
CA2879589C (en) * 2012-07-27 2021-02-02 Biogen Idec Ma Inc. Compounds that are sip modulating agents and/or atx modulating agents
JP6133427B2 (ja) 2012-09-14 2017-05-24 スパーナス ファーマシューティカルズ インコーポレイテッド モリンドン及びその塩の製造方法
KR102524421B1 (ko) * 2017-09-07 2023-04-21 뉴소아라 바이오파마 컴퍼니 리미티드 벤젠 축합 헤테로환 유도체 및 이를 포함하는 약학 조성물
CN115073435B (zh) * 2022-06-24 2023-11-28 西北大学 一种检测硫化氢的近红外荧光探针及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2820817A (en) * 1954-02-04 1958-01-21 Mcneilab Inc Oxygenated indan compounds and method of making the same
GB1140990A (en) * 1967-05-05 1969-01-22 Warner Lambert Pharmaceutical Novel 1,2,3,4-tetrahydro-naphthalen-2-ones and a process for the preparation thereof
US3547923A (en) * 1968-03-25 1970-12-15 Bristol Myers Co Piperazyl ethyl 7h-benzocycloheptenes
US3644372A (en) * 1970-01-14 1972-02-22 Mcneilab Inc 1-(4-piperidyl) indenes
US3850935A (en) * 1971-10-16 1974-11-26 Sumitomo Chemical Co Process for producing piperidine derivatives by degrading quaternary piperidinium salts
US3974212A (en) * 1974-05-22 1976-08-10 Merck & Co., Inc. [1-Hydroximino-2,2-disubstituted-5-indanyloxy-(or thio)]alkanoic acids

Also Published As

Publication number Publication date
LU74390A1 (hu) 1977-09-12
US4016281A (en) 1977-04-05
DK72476A (da) 1976-08-23
CS190549B2 (en) 1979-05-31
ATA124376A (de) 1979-04-15
AT353270B (de) 1979-11-12
CS190525B2 (en) 1979-05-31
IE42486L (en) 1976-08-22
HU173756B (hu) 1979-08-28
FR2301253B1 (hu) 1979-09-21
DD124977A5 (hu) 1977-03-23
IL49080A0 (en) 1976-04-30
IE42486B1 (en) 1980-08-13
JPS51110573A (hu) 1976-09-30
GB1477293A (en) 1977-06-22
ES445367A1 (es) 1977-10-01
SE7601962L (sv) 1976-08-23
FR2301253A1 (fr) 1976-09-17
CA1081233A (en) 1980-07-08
NL7601762A (nl) 1976-08-24

Similar Documents

Publication Publication Date Title
IL49238A (en) O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL56155A (en) Substituted alkanoylanilide derivatives,their preparation and pharmaceutical compositions comprising them
IL50176A0 (en) Novel tetrahydroisoquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL51074A (en) Isoquinolinium derivatives,their preparation and pharmaceutical compositions containing them
IL49911A0 (en) New 5-aroylpyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL49359A0 (en) New erythromycin derivatives,their preparation and pharmaceutical compositions containing them
IL53043A (en) N-heterocyclylalkyl-(1-aryloxy-2-hydroxy-3-amino-propane)derivatives,their preparation and pharmaceutical compositions containing them
IL49022A0 (en) Isoxazolylbenzamide derivatives,their production and pharmaceutical compositions containing them
IL50690A0 (en) Novel benzisothiazole derivatives,their preparation and pharmaceutical compositions containing them
IL50869A (en) Heterocyclylthio-ethylimidazole derivatives,their preparation and pharmaceutical compositions containing them
IL49080A (en) 4-hydroxy-4-(substituted)phenyl-piperidinomethyl-2-tetralone(or indanone)derivatives, their preparation and pharmaceutical compositions comprising them
IL50631A0 (en) 1-benzazolylalkyl-4-substituted-piperidines,their preparation and pharmaceutical compositions containing them
IL49194A0 (en) Novel thiocarbamide derivatives,their preparation and pharmaceutical compositions containing them
IL49424A0 (en) 1,1,1-triaryl-alkylamines,their preparation and pharmaceutical compositions containing them
IL49788A0 (en) 11-desoxy-16-aryloxy-omega-pentanorprostaglandins,their preparation and pharmaceutical compositions containing them
IL50335A (en) Diphenylalkylpolyamine derivatives,their preparation and pharmaceutical compositions containing them
IL49132A (en) 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
IL49360A0 (en) New erythromycin derivatives,their preparation and pharmaceutical compositions containing them
IL50156A0 (en) New homophthalimide derivatives,their preparation and pharmaceutical compositions containing them
IL53861A0 (en) Novel n-aralkylaniline derivatives, their preparation and pharmaceutical compositions containing them
IL49971A0 (en) New 2-benzoypranone derivatives,their preparation and pharmaceutical compositions containing them
IL49099A (en) Xanthene-9-carboxylates, their preparation and pharmaceutical compositions containing them
IL49319A (en) 4,4-diphenyl-2-hydroxy butylamine derivatives their preparation and pharmaceutical compositions containing them
IL55095A0 (en) Novel piperidino-propanol derivatives,their preparation and pharmaceutical compositions containing them
IL50554A (en) 2,9-dioxatricyclodecanes,their preparation and pharmaceutical compositions containing them